A share price of Quest Diagnostics, Inc. [DGX] is currently trading at $127.39, up 0.37%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DGX shares have gain 2.00% over the last week, with a monthly amount glided 0.89%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Quest Diagnostics, Inc. [NYSE: DGX] stock has seen the most recent analyst activity on February 26, 2024, when Leerink Partners initiated its Market Perform rating and assigned the stock a price target of $135. Previously, Jefferies upgraded its rating to Buy on February 07, 2024, and elevated its price target to $155. On January 03, 2024, Barclays initiated with a Equal Weight rating and assigned a price target of $145 on the stock. BofA Securities upgraded its rating to a Buy and increased its price target to $160 on December 12, 2023. Piper Sandler initiated its recommendation with a Neutral. BofA Securities downgraded its rating to Neutral for this stock on May 02, 2023, and downed its price target to $148. In a note dated April 03, 2023, Citigroup upgraded an Neutral rating on this stock and boosted its target price from $125 to $142.
Quest Diagnostics, Inc. experienced fluctuations in its stock price throughout the past year between $119.59 and $148.62. Currently, Wall Street analysts expect the stock to reach $155.5 within the next 12 months. Quest Diagnostics, Inc. [NYSE: DGX] shares were valued at $127.39 at the most recent close of the market. An investor can expect a potential return of 22.07% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Trailing Twelve Months sales for Quest Diagnostics, Inc. [NYSE:DGX] were 9.25B which represents -1.93% decline. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.14 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 126.78 points at the first support level, and at 126.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 127.86, and for the 2nd resistance point, it is at 128.34.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Quest Diagnostics, Inc. [NYSE:DGX] is 1.31. Further, the Quick Ratio stands at 1.20, while the Cash Ratio is 0.38. Considering the valuation of this stock, the price to sales ratio is 1.52, the price to book ratio is 2.24 and price to earnings (TTM) ratio is 17.02.
Transactions by insiders
Recent insider trading involved PREVOZNIK MICHAEL E, SVP & General Counsel, that happened on Feb 29 ’24 when 5611.0 shares were sold. EVP, Regional Businesses, Doherty Catherine T. completed a deal on Feb 29 ’24 to sell 1187.0 shares. Meanwhile, EVP, Regional Businesses Doherty Catherine T. sold 5557.0 shares on Feb 28 ’24.
